The HRA will be joining other regulators in a working group to support this bold and exciting new Commission, which will help accelerate safe access to AI in healthcare. Our Non-Executive Director Alastair Denniston will be chairing the Commission, which will advise the Medicines and Healthcare products Regulatory Agency on a world-leading framework for the regulation of AI products. Read our news story to hear more from Alastair and our Chief Executive Matthew Westmore (he/him): https://lnkd.in/eS9b65MW
📣 New Commission to help accelerate NHS use of AI We have today launched the UK National Commission on the Regulation of AI in Healthcare to help accelerate safe access to AI in healthcare. This expert group – bringing together global tech leaders, clinicians, and regulators – will: • Advise the MHRA on a new regulatory framework, to be published next year. • Review AI tech currently held back by regulatory uncertainty, such as AI assistants that take notes for doctors • Drive forward the government’s plan to build an NHS fit for the future and accelerate access to cutting-edge AI tools As Lawrence Tallon explains in this video, the Commission’s work will ensure patients benefit from innovation quickly and safely, while making the UK a global leader in responsible AI healthcare regulation. 📖 Read the full press release: https://bit.ly/42K7du7 #AI #HealthcareInnovation #NHS #DigitalHealth #MHRA
Phil Collis
1mo
Shared decision making ..clinicians, patients and verified and validated AI use that is safe for everyone..
Prioritizing Patient Access and Bridging Clinical Trials to the World Founder/ CEO @ Ascend Clinical Research | Global Clinical Trial Delivery and Participant Recruitment Solutions/ GCP Educator
1moMuch awaited! Hope this will help guide us on safe AI use and what is acceptable and not